Cargando…

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit()

OBJECTIVE: To describe the prevalence of atrial fibrillation (AF) in patients with rheumatoid arthritis (RA), and to evaluate the proportion of patients with AF receiving guideline-recommended anticoagulation for prevention of stroke, based on data from a large international audit. METHODS: The coho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semb, Anne Grete, Rollefstad, Silvia, Sexton, Joseph, Ikdahl, Eirik, Crowson, Cynthia S., van Riel, Piet, Kitas, George, Graham, Ian, Kerola, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479366/ https://www.ncbi.nlm.nih.gov/pubmed/36118256 http://dx.doi.org/10.1016/j.ijcha.2022.101117

Ejemplares similares

A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA
por: Semb, Anne Grete, et al.
Publicado: (2022)

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
por: Crowson, Cynthia S., et al.
Publicado: (2017)

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
por: Crowson, Cynthia S., et al.
Publicado: (2017)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Kerola, Anne Mirjam, et al.
Publicado: (2021)

EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic
por: Ikdahl, Eirik, et al.
Publicado: (2015)

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
por: Semb, Anne Grete, et al.
Publicado: (2021)

All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study
por: Kerola, Anne M, et al.
Publicado: (2022)

Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases
por: Svanteson, Mona, et al.
Publicado: (2019)

Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases
por: Rollefstad, Silvia, et al.
Publicado: (2015)

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
por: Roelsgaard, Ida K, et al.
Publicado: (2020)

Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases
por: Svanteson, Mona, et al.
Publicado: (2017)

Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study
por: Os, Hanna A, et al.
Publicado: (2020)

Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
por: Ikdahl, Eirik, et al.
Publicado: (2016)

Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study
por: Ikdahl, Eirik, et al.
Publicado: (2015)

Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models
por: Wibetoe, Grunde, et al.
Publicado: (2020)

Increased Incidence of Atrial Fibrillation in Patients with Rheumatoid Arthritis
por: Bacani, A. Kirstin, et al.
Publicado: (2015)

The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease
por: Fagerhøi, Maria Grorud, et al.
Publicado: (2018)

Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
por: Kerola, Anne M., et al.
Publicado: (2022)

Case Fatality of Patients With Type 1 Diabetes After Myocardial Infarction
por: Kerola, Anne M., et al.
Publicado: (2022)

Cardiovascular disease risk profiles in inflammatory joint disease entities
por: Wibetoe, Grunde, et al.
Publicado: (2017)

Serum Samples That Have Been Stored Long-Term (>10 Years) Can Be Used as a Suitable Data Source for Developing Cardiovascular Risk Prediction Models in Large Observational Rheumatoid Arthritis Cohorts
por: Arts, Elke E. A., et al.
Publicado: (2014)

The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial
por: Roelsgaard, Ida Kristiane, et al.
Publicado: (2017)

Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project
por: Ikdahl, Eirik, et al.
Publicado: (2018)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
por: Choy, Ernest, et al.
Publicado: (2014)

Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT)
por: Gulati, Agnete Malm, et al.
Publicado: (2018)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Cardioversion of Atrial Arrhythmias: Audit of Anticoagulation Management
por: Mayet, Jamil, et al.
Publicado: (1997)

How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study
por: Roelsgaard, Ida Kristiane, et al.
Publicado: (2020)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibm7ujqknimme7to2gq0b3q2va